International Journal of Vascular Medicine · Published 2025-01-01 · DOI 10.1155/ijvm/9668464
Conclusion: CAC is a viable alternative to RFA, demonstrated equivalent occlusion rates, though CAC exhibited a higher incidence of phlebitis. Careful patient selection and perioperative management may help mitigate risks. Further studies with larger cohorts and longer follow-up are needed to optimize treatment protocols and long-term outcomes.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →